Retatrutide in India: The Complete Guide to Sourcing, Dosing & Results (2025)
Retatrutide is the most powerful weight loss peptide ever studied — 24% body weight reduction in trials. Here's everything about sourcing it in India, dosing protocols, and what to expect.
Retatrutide is the first triple agonist peptide to enter clinical trials — hitting GIP, GLP-1, and glucagon receptors simultaneously. In Phase 2 trials, participants lost an average of 24.2% of their body weight over 48 weeks. For context, semaglutide delivers ~15% and tirzepatide ~22%. Retatrutide is in a different class.
What Is Retatrutide?
Retatrutide (LY3437943) is a once-weekly injectable peptide developed by Eli Lilly. Unlike semaglutide (GLP-1 only) or tirzepatide (GLP-1 + GIP), retatrutide hits three receptors:
- GLP-1 receptor — appetite suppression, slows gastric emptying
- GIP receptor — enhances insulin secretion, fat storage regulation
- Glucagon receptor — increases energy expenditure, drives fat oxidation
The glucagon component is what sets it apart. Glucagon agonism increases your resting metabolic rate — you burn more calories doing nothing. Combined with GLP-1 appetite suppression, the effect is dramatically stronger than dual agonists.
Clinical Trial Results
In the Phase 2 TRIUMPH-1 trial (2023):
- 4mg dose: 17.5% weight loss at 24 weeks
- 8mg dose: 22.8% weight loss at 24 weeks
- 12mg dose: 24.2% weight loss at 24 weeks
- Placebo: 2.1% weight loss
Importantly, weight loss had not plateaued at 48 weeks — the curve was still descending, suggesting even greater long-term results.
Retatrutide Dosing Protocol
Research protocols follow a slow titration to minimize GI side effects:
- Weeks 1–4: 0.5mg once weekly
- Weeks 5–8: 1mg once weekly
- Weeks 9–12: 2mg once weekly
- Weeks 13–16: 4mg once weekly (maintenance for most)
- Weeks 17–24: 8mg once weekly (advanced)
Subcutaneous injection, abdomen or thigh. Rotate injection sites weekly.
Sourcing Retatrutide in India
Retatrutide is not yet approved for clinical use anywhere in the world — it is in Phase 3 trials. In India, it is available only as a research peptide. Prescription Ozempic in India costs ₹15,000–25,000 per month. Research-grade retatrutide from a direct-source vendor like PeptideBazaar costs a fraction of that.
When sourcing, always verify:
- HPLC certificate of analysis (≥98% purity minimum)
- Lyophilized (freeze-dried) format — not pre-mixed
- Cold-pack shipping
- Traceable batch numbers
Storage and Reconstitution
Lyophilized retatrutide is stable at room temperature for months. Once reconstituted with bacteriostatic water, store at 2–8°C and use within 28 days. Never freeze reconstituted peptide — it degrades the structure.
Side Effects
Most common (mirror other GLP-1 class): nausea, reduced appetite, mild fatigue in weeks 1–4. The glucagon component can cause mild increases in heart rate. Titrate slowly and these resolve. Not for use in type 1 diabetics or those with personal/family history of medullary thyroid carcinoma.
Bottom Line
Retatrutide is the most powerful weight loss compound ever studied in humans. The research data is unambiguous. For those in India seeking research-grade access at fair prices, PeptideBazaar sources directly and passes the savings on.